Imagin Medical Inc. (IMEXF)

[lithiumjr]

$IMEXF RESEARCH STUDY LISTED ON GOVERNMENT WEBSITE expects study to confirm bench test results

https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aIME-2513098&symbol=IME®ion=C

The information about the coming clinical research study at the University of Rochester announced in a press release on Sept. 27, 2017, can be found on a government website maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH).

The pilot study entitled, Near Infrared Fluorescence Imaging for Bladder Cancer Detection, is sponsored by Dr. Edward Messing, Chair of Urology at the University of Rochester Medical Center, and the study's principal investigator. The primary purpose of the study is to determine the minimal dwell time needed for adequate detection of cancerous cells using protoporphyrin IX (PpIX) near infrared fluorescence (NIRF). Imagin anticipates the study will prove that surgeons will be able to "see" the cancerous cells in less than 15 minutes, one of the key features of the i/Blue technology. The Study will also evaluate another feature of the i/Blue System, the patented Simultaneous Acquisition of Differing Images, which will blend the white light and fluorescing images into one, enabling the surgeon, in one step, to identify the precise location of the of the cancerous cells within the bladder.

"We're eager for this study to begin," commented Jim Hutchens, Imagin Medical's President and CEO. "We expect the outcome to confirm our bench test results and build on the company's momentum."

The NIH database contains information about medical studies in human volunteers for both federally and privately funded trials, describing the purpose of the studies conducted in all 50 States and in 197 countries. Each study record presents summary information about the study protocol, including the medical product, behavior, or procedure being studied, as well as requirements for participation and study outcomes.